IBT
International Biotechnology Trust Portfolio holdings
AUM
$297M
This Quarter Return
+7.26%
1 Year Return
+17.25%
3 Year Return
+11.14%
5 Year Return
+79.35%
10 Year Return
–
AUM
$263M
AUM Growth
+$263M
(+0.73%)
Cap. Flow
-$9.6M
Cap. Flow
% of AUM
-3.65%
Top 10 Holdings %
Top 10 Hldgs %
51.63%
Holding
68
New
8
Increased
22
Reduced
13
Closed
8
Top Buys
| 1 |
Viatris
VTRS
|
$5.43M |
| 2 |
RDUS
Radius Health, Inc.
RDUS
|
$4.3M |
| 3 |
AERI
Aerie Pharmaceuticals, Inc.
AERI
|
$4.14M |
| 4 |
BioMarin Pharmaceuticals
BMRN
|
$3.68M |
| 5 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
$2.81M |
Top Sells
| 1 |
Supernus Pharmaceuticals
SUPN
|
$7.71M |
| 2 |
Illumina
ILMN
|
$7.63M |
| 3 |
Incyte
INCY
|
$6.3M |
| 4 |
SHPG
Shire pic
SHPG
|
$5.87M |
| 5 |
Bristol-Myers Squibb
BMY
|
$5.33M |
Sector Composition
| 1 | Healthcare | 87.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Regeneron Pharmaceuticals
REGN
$61.5B
| $23.6M | 8.98% | 48,130 +3,000 | +7% | +$1.47M |
|
|
CELG
2
DELISTED
Celgene Corp
CELG
| $23.1M | 8.76% | 177,522 +3,500 | +2% | +$455K |
|
3
Vertex Pharmaceuticals
VRTX
$100B
| $17.5M | 6.64% | 135,522 +13,000 | +11% | +$1.68M |
|
4
Biogen
BIIB
$19.4B
| $16.6M | 6.3% | 61,108 -14,300 | -19% | -$3.88M |
|
|
ALXN
5
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $11.8M | 4.47% | 96,641 -28,000 | -22% | -$3.41M |
|
|
6
BioMarin Pharmaceuticals
BMRN
$11.2B
| $10.7M | 4.08% | 118,166 +40,500 | +52% | +$3.68M |
|
|
7
Incyte
INCY
$16.5B
| $9.76M | 3.71% | 77,475 -50,000 | -39% | -$6.3M |
|
8
Amgen
AMGN
$155B
| $8.63M | 3.28% | 50,104 -17,000 | -25% | -$2.93M |
|
9
Gilead Sciences
GILD
$140B
| $8.62M | 3.28% | 121,784 +20,000 | +20% | +$1.42M |
|
|
ENTL
10
DELISTED
Entellus Medical, Inc. Common Stock
ENTL
| $5.66M | 2.15% | 341,468 | – | – |
|
|
11
Viatris
VTRS
$12.3B
| $5.43M | 2.06% | +140,000 | New | +$5.43M |
|
|
SHPG
12
DELISTED
Shire pic
SHPG
| $5.4M | 2.05% | 32,700 -35,500 | -52% | -$5.87M |
|
|
XLRN
13
DELISTED
Acceleron Pharma Inc.
XLRN
| $5.4M | 2.05% | 177,643 +7,037 | +4% | +$214K |
|
|
RDUS
14
DELISTED
Radius Health, Inc.
RDUS
| $5.19M | 1.97% | 114,799 +95,000 | +480% | +$4.3M |
|
15
Exelixis
EXEL
$10.1B
| $5.1M | 1.94% | 207,000 +76,000 | +58% | +$1.87M |
|
|
NDRM
16
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
| $5.01M | 1.9% | 168,025 +59,777 | +55% | +$1.78M |
|
|
AERI
17
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $4.93M | 1.87% | 93,822 +78,822 | +525% | +$4.14M |
|
|
TSRO
18
DELISTED
TESARO, Inc.
TSRO
| $4.69M | 1.78% | 33,500 +10,000 | +43% | +$1.4M |
|
|
PTLA
19
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $4.27M | 1.62% | 76,000 +50,000 | +192% | +$2.81M |
|
20
Jazz Pharmaceuticals
JAZZ
$7.75B
| $4.2M | 1.6% | 27,000 | – | – |
|
|
STML
21
DELISTED
Stemline Therapeutics, Inc.
STML
| $4.17M | 1.58% | 453,000 +123,000 | +37% | +$1.13M |
|
22
Acadia Pharmaceuticals
ACAD
$4.38B
| $3.84M | 1.46% | 137,773 +88,122 | +177% | +$2.46M |
|
|
DERM
23
DELISTED
Dermira, Inc.
DERM
| $3.76M | 1.43% | 129,000 +24,000 | +23% | +$699K |
|
|
CALA
24
DELISTED
Calithera Biosciences, Inc
CALA
| $3.62M | 1.38% | 244,000 +150,701 | +162% | +$2.24M |
|
|
SGYP
25
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
| $3.43M | 1.3% | 772,000 +460,000 | +147% | +$2.04M |
|